

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21553725 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92921838 |
| 3 | negative T cell selection (GO:0043383) | 4.87404599 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.65762659 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.65762659 |
| 6 | negative thymic T cell selection (GO:0045060) | 4.50055124 |
| 7 | activated T cell proliferation (GO:0050798) | 4.43986552 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.40774289 |
| 9 | central nervous system myelination (GO:0022010) | 4.24337295 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 4.24337295 |
| 11 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.19157999 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.06210772 |
| 13 | positive T cell selection (GO:0043368) | 4.00625321 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 3.98779452 |
| 15 | tolerance induction (GO:0002507) | 3.97526744 |
| 16 | response to interleukin-15 (GO:0070672) | 3.87663965 |
| 17 | negative regulation of T cell mediated immunity (GO:0002710) | 3.75893651 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 3.72621910 |
| 19 | fatty acid elongation (GO:0030497) | 3.70327954 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70209366 |
| 21 | cellular extravasation (GO:0045123) | 3.70106215 |
| 22 | RNA destabilization (GO:0050779) | 3.53481972 |
| 23 | cytidine deamination (GO:0009972) | 3.51181351 |
| 24 | cytidine metabolic process (GO:0046087) | 3.51181351 |
| 25 | cytidine catabolic process (GO:0006216) | 3.51181351 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.49944008 |
| 27 | regulation of T cell tolerance induction (GO:0002664) | 3.47296896 |
| 28 | interferon-gamma production (GO:0032609) | 3.45914590 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43646212 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43448246 |
| 31 | neutrophil activation (GO:0042119) | 3.41669661 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41609806 |
| 33 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.40493537 |
| 34 | T cell selection (GO:0045058) | 3.40061844 |
| 35 | leukocyte aggregation (GO:0070486) | 3.37326351 |
| 36 | response to lipoprotein particle (GO:0055094) | 3.32018170 |
| 37 | positive regulation of tolerance induction (GO:0002645) | 3.31731521 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.27252582 |
| 39 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.25901185 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25143865 |
| 41 | negative regulation of neurotransmitter transport (GO:0051589) | 3.24098055 |
| 42 | T cell migration (GO:0072678) | 3.22020961 |
| 43 | ensheathment of neurons (GO:0007272) | 3.21968752 |
| 44 | axon ensheathment (GO:0008366) | 3.21968752 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 3.20400684 |
| 46 | creatine metabolic process (GO:0006600) | 3.19771319 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.19591818 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.19591818 |
| 49 | granulocyte activation (GO:0036230) | 3.18370290 |
| 50 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17217554 |
| 51 | myelination (GO:0042552) | 3.15938499 |
| 52 | protein localization to endosome (GO:0036010) | 3.14772505 |
| 53 | mast cell activation (GO:0045576) | 3.14190261 |
| 54 | response to type I interferon (GO:0034340) | 3.13419062 |
| 55 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.09147128 |
| 56 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.09147128 |
| 57 | myelin maintenance (GO:0043217) | 3.08886596 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07788955 |
| 59 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.07756349 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.06634761 |
| 61 | thymic T cell selection (GO:0045061) | 3.05624952 |
| 62 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04204057 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 3.04028179 |
| 64 | virion attachment to host cell (GO:0019062) | 3.04028179 |
| 65 | glycerophospholipid catabolic process (GO:0046475) | 3.02723082 |
| 66 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02230686 |
| 67 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02230686 |
| 68 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.01997663 |
| 69 | T-helper cell differentiation (GO:0042093) | 3.01997663 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 3.01610394 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00808985 |
| 72 | amyloid precursor protein catabolic process (GO:0042987) | 2.97457715 |
| 73 | growth hormone receptor signaling pathway (GO:0060396) | 2.96794204 |
| 74 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.95543839 |
| 75 | actin nucleation (GO:0045010) | 2.92435830 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.90018984 |
| 77 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.89165629 |
| 78 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.89165629 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 2.88807374 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.88540667 |
| 81 | response to redox state (GO:0051775) | 2.88380609 |
| 82 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.88102804 |
| 83 | positive regulation of granulocyte differentiation (GO:0030854) | 2.87350571 |
| 84 | photoreceptor cell differentiation (GO:0046530) | 2.86423643 |
| 85 | eye photoreceptor cell differentiation (GO:0001754) | 2.86423643 |
| 86 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85462602 |
| 87 | membrane tubulation (GO:0097320) | 2.84941769 |
| 88 | alpha-beta T cell differentiation (GO:0046632) | 2.83808815 |
| 89 | regulation of B cell differentiation (GO:0045577) | 2.83301964 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82608519 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82608519 |
| 92 | DNA deamination (GO:0045006) | 2.82461799 |
| 93 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.82344869 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 2.81633144 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80024619 |
| 96 | alpha-beta T cell activation (GO:0046631) | 2.79805282 |
| 97 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.78811342 |
| 98 | regulation of cell killing (GO:0031341) | 2.77697455 |
| 99 | positive regulation of mRNA catabolic process (GO:0061014) | 2.77174173 |
| 100 | negative regulation of inclusion body assembly (GO:0090084) | 2.77155328 |
| 101 | detection of other organism (GO:0098543) | 2.75659094 |
| 102 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.74502957 |
| 103 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.74502957 |
| 104 | T cell differentiation involved in immune response (GO:0002292) | 2.74502957 |
| 105 | neutrophil mediated immunity (GO:0002446) | 2.73425313 |
| 106 | dendritic cell migration (GO:0036336) | 2.73202619 |
| 107 | positive regulation of B cell differentiation (GO:0045579) | 2.73123983 |
| 108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.71792429 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70207963 |
| 110 | negative regulation of adaptive immune response (GO:0002820) | 2.69998698 |
| 111 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.68970867 |
| 112 | negative regulation of B cell proliferation (GO:0030889) | 2.68651830 |
| 113 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.67247124 |
| 114 | defense response to protozoan (GO:0042832) | 2.66016317 |
| 115 | positive regulation of cell killing (GO:0031343) | 2.65474490 |
| 116 | regulation of female gonad development (GO:2000194) | 2.57571910 |
| 117 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.56470136 |
| 118 | cellular response to growth hormone stimulus (GO:0071378) | 2.54284795 |
| 119 | adhesion of symbiont to host (GO:0044406) | 2.53365086 |
| 120 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.53323392 |
| 121 | response to methylmercury (GO:0051597) | 2.49006946 |
| 122 | protein K11-linked deubiquitination (GO:0035871) | 2.48997497 |
| 123 | presynaptic membrane assembly (GO:0097105) | 2.46725912 |
| 124 | Rap protein signal transduction (GO:0032486) | 2.41993260 |
| 125 | asymmetric protein localization (GO:0008105) | 2.35733797 |
| 126 | amyloid precursor protein metabolic process (GO:0042982) | 2.34953431 |
| 127 | glycosylceramide metabolic process (GO:0006677) | 2.34522910 |
| 128 | peripheral nervous system axon ensheathment (GO:0032292) | 2.34172034 |
| 129 | myelination in peripheral nervous system (GO:0022011) | 2.34172034 |
| 130 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.32771543 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 2.31946309 |
| 132 | positive regulation of interleukin-17 production (GO:0032740) | 2.29211277 |
| 133 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.27064184 |
| 134 | membrane protein ectodomain proteolysis (GO:0006509) | 2.25330553 |
| 135 | L-phenylalanine catabolic process (GO:0006559) | 2.25253176 |
| 136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.25253176 |
| 137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.24698146 |
| 138 | multicellular organism reproduction (GO:0032504) | 2.24343592 |
| 139 | oligodendrocyte differentiation (GO:0048709) | 2.23709797 |
| 140 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.21435980 |
| 141 | import into cell (GO:0098657) | 2.20677380 |
| 142 | intracellular pH reduction (GO:0051452) | 2.20086737 |
| 143 | regulation of extracellular matrix disassembly (GO:0010715) | 2.19796950 |
| 144 | ER overload response (GO:0006983) | 2.18816449 |
| 145 | membrane raft organization (GO:0031579) | 2.14683873 |
| 146 | nerve growth factor signaling pathway (GO:0038180) | 2.13323485 |
| 147 | opsonization (GO:0008228) | 2.10843833 |
| 148 | cellular ketone body metabolic process (GO:0046950) | 2.10310024 |
| 149 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.07078592 |
| 150 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.05372399 |
| 151 | pH reduction (GO:0045851) | 2.01797864 |
| 152 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.01357621 |
| 153 | establishment of endothelial barrier (GO:0061028) | 2.00797877 |
| 154 | negative regulation of exocytosis (GO:0045920) | 1.99929626 |
| 155 | presynaptic membrane organization (GO:0097090) | 1.99914726 |
| 156 | muscle cell migration (GO:0014812) | 1.97073115 |
| 157 | apical protein localization (GO:0045176) | 1.96461874 |
| 158 | negative regulation of protein localization to cell surface (GO:2000009) | 1.96399204 |
| 159 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.95949133 |
| 160 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 1.95754792 |
| 161 | regulation of mononuclear cell migration (GO:0071675) | 1.95723412 |
| 162 | cerebral cortex radially oriented cell migration (GO:0021799) | 1.95480171 |
| 163 | cholesterol biosynthetic process (GO:0006695) | 1.93498485 |
| 164 | regulation of energy homeostasis (GO:2000505) | 1.93440102 |
| 165 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.92705704 |
| 166 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.92705704 |
| 167 | modulation by symbiont of host immune response (GO:0052553) | 1.92705704 |
| 168 | positive regulation by symbiont of host defense response (GO:0052509) | 1.92705704 |
| 169 | modulation by symbiont of host defense response (GO:0052031) | 1.92705704 |
| 170 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.92705704 |
| 171 | intracellular lipid transport (GO:0032365) | 1.91518330 |
| 172 | localization within membrane (GO:0051668) | 1.91377043 |
| 173 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 1.91190642 |
| 174 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 1.90878553 |
| 175 | positive regulation of p38MAPK cascade (GO:1900745) | 1.89998192 |
| 176 | long-chain fatty acid biosynthetic process (GO:0042759) | 1.88642198 |
| 177 | signal peptide processing (GO:0006465) | 1.88414952 |
| 178 | phagocytosis, engulfment (GO:0006911) | 1.88324413 |
| 179 | regulation of lipoprotein metabolic process (GO:0050746) | 1.87043870 |
| 180 | regulation of RIG-I signaling pathway (GO:0039535) | 1.86599545 |
| 181 | reproduction (GO:0000003) | 1.86507504 |
| 182 | nucleotide transmembrane transport (GO:1901679) | 1.86419802 |
| 183 | keratan sulfate catabolic process (GO:0042340) | 1.86406090 |
| 184 | sperm capacitation (GO:0048240) | 1.85891573 |
| 185 | respiratory burst (GO:0045730) | 1.80986158 |
| 186 | membrane protein intracellular domain proteolysis (GO:0031293) | 1.80851845 |
| 187 | regulation of activation of Janus kinase activity (GO:0010533) | 1.80707999 |
| 188 | type B pancreatic cell development (GO:0003323) | 1.80106017 |
| 189 | ovulation cycle (GO:0042698) | 1.79460869 |
| 190 | myoblast migration (GO:0051451) | 1.77622429 |
| 191 | regulation of macrophage chemotaxis (GO:0010758) | 1.76986937 |
| 192 | positive regulation of vasculogenesis (GO:2001214) | 1.76679700 |
| 193 | blood vessel maturation (GO:0001955) | 1.76470104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.14828829 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.87507169 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.57041659 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.54582444 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.41632268 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.39943572 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 2.14286801 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03484097 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.84204866 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77300081 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77113730 |
| 12 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.73690105 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72393715 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66928619 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.66576663 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60104049 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58262663 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57010121 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54666108 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 1.53982388 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49779171 |
| 22 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49148493 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48856819 |
| 24 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47952793 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44219087 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42219508 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40593690 |
| 28 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37948173 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37948173 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33633626 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32590286 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32212496 |
| 33 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31413553 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30998204 |
| 35 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29738579 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28836386 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.28243492 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27940077 |
| 39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27517610 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26715281 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26548823 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25688954 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25532629 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24105269 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23480124 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23382381 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23240553 |
| 48 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22802253 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22019761 |
| 50 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21280765 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20875774 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20111845 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17508346 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16461990 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16337975 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15933237 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13950936 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13524811 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13372609 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13225687 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13000987 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11687211 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11594931 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10483779 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08428865 |
| 66 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07996556 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07621619 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.07316696 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06902572 |
| 70 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06617833 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06026012 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05752434 |
| 73 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05225499 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04961593 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04018274 |
| 76 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03839076 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03767972 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03393543 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02861480 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02672322 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02672322 |
| 82 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01557419 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99985804 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99965236 |
| 85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98716364 |
| 86 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98688229 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98557160 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97526921 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97049991 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96021995 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95390989 |
| 92 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95368761 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95135106 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93256984 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93135784 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92805495 |
| 97 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92704420 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92167817 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91992169 |
| 100 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91908175 |
| 101 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.91865356 |
| 102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90593415 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90593415 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90274572 |
| 105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90217327 |
| 106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89726158 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89135747 |
| 108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88591786 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88244404 |
| 110 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.87186844 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86990961 |
| 112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86828025 |
| 113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86771880 |
| 114 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86617838 |
| 115 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86297066 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86077360 |
| 117 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85358555 |
| 118 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85127596 |
| 119 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85127596 |
| 120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85079137 |
| 121 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84952748 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84919565 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84892667 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84870124 |
| 125 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.84457110 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84373714 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83627127 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83337392 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83243709 |
| 130 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82942051 |
| 131 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.82712123 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82580654 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.82427841 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82297282 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82192499 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81467212 |
| 137 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.81252341 |
| 138 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80871899 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80529422 |
| 140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80506375 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79389698 |
| 142 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79135521 |
| 143 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79124191 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78814633 |
| 145 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78599279 |
| 146 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78495479 |
| 147 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78390161 |
| 148 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.77990464 |
| 149 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77940409 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77935990 |
| 151 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.77910006 |
| 152 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.77691871 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.77591632 |
| 154 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77580846 |
| 155 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.77351826 |
| 156 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77143808 |
| 157 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.77125020 |
| 158 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77016752 |
| 159 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.76188194 |
| 160 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76125435 |
| 161 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76069010 |
| 162 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.76057551 |
| 163 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.75938231 |
| 164 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.75739403 |
| 165 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75049952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.60617856 |
| 2 | MP0005451_abnormal_body_composition | 3.32585629 |
| 3 | MP0006054_spinal_hemorrhage | 2.89520132 |
| 4 | MP0001800_abnormal_humoral_immune | 2.76769836 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.55947573 |
| 6 | MP0005410_abnormal_fertilization | 2.54642868 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.53876288 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.45804418 |
| 9 | MP0009840_abnormal_foam_cell | 2.39008326 |
| 10 | MP0006082_CNS_inflammation | 2.33494916 |
| 11 | MP0003690_abnormal_glial_cell | 2.33373458 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.27426555 |
| 13 | MP0002163_abnormal_gland_morphology | 2.17898262 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.09725744 |
| 15 | MP0003787_abnormal_imprinting | 2.07635579 |
| 16 | MP0002933_joint_inflammation | 2.05081769 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.00523113 |
| 18 | MP0005058_abnormal_lysosome_morphology | 1.97052782 |
| 19 | MP0002009_preneoplasia | 1.96582407 |
| 20 | MP0003950_abnormal_plasma_membrane | 1.92718403 |
| 21 | MP0005171_absent_coat_pigmentation | 1.89346608 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.89170727 |
| 23 | MP0004043_abnormal_pH_regulation | 1.87814647 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.85798798 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 1.83701795 |
| 26 | MP0002405_respiratory_system_inflammati | 1.80506557 |
| 27 | MP0002398_abnormal_bone_marrow | 1.75954165 |
| 28 | MP0000716_abnormal_immune_system | 1.74182851 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.73548573 |
| 30 | MP0000343_altered_response_to | 1.72953372 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.68579682 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.64306239 |
| 33 | MP0003646_muscle_fatigue | 1.63960295 |
| 34 | MP0000685_abnormal_immune_system | 1.60988649 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60957442 |
| 36 | MP0003075_altered_response_to | 1.60660984 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.59505432 |
| 38 | MP0003303_peritoneal_inflammation | 1.57717565 |
| 39 | MP0005365_abnormal_bile_salt | 1.55442049 |
| 40 | MP0001851_eye_inflammation | 1.54838957 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.48242290 |
| 42 | MP0001790_abnormal_immune_system | 1.46830990 |
| 43 | MP0005387_immune_system_phenotype | 1.46830990 |
| 44 | MP0004381_abnormal_hair_follicle | 1.45456003 |
| 45 | MP0005310_abnormal_salivary_gland | 1.45344919 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.42943534 |
| 47 | MP0003866_abnormal_defecation | 1.42799145 |
| 48 | MP0003195_calcinosis | 1.41163139 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.41063345 |
| 50 | MP0002419_abnormal_innate_immunity | 1.39465020 |
| 51 | MP0004134_abnormal_chest_morphology | 1.38632418 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.38592177 |
| 53 | MP0003724_increased_susceptibility_to | 1.38006889 |
| 54 | MP0002722_abnormal_immune_system | 1.37897832 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.36823485 |
| 56 | MP0005360_urolithiasis | 1.34914589 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.34817695 |
| 58 | MP0004130_abnormal_muscle_cell | 1.33644438 |
| 59 | MP0003436_decreased_susceptibility_to | 1.33211274 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.32170095 |
| 61 | MP0002006_tumorigenesis | 1.30987901 |
| 62 | MP0004947_skin_inflammation | 1.28858791 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.28351504 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.26684537 |
| 65 | MP0008469_abnormal_protein_level | 1.25350154 |
| 66 | MP0000579_abnormal_nail_morphology | 1.25039513 |
| 67 | MP0009384_cardiac_valve_regurgitation | 1.24973750 |
| 68 | MP0003045_fibrosis | 1.24900683 |
| 69 | MP0002429_abnormal_blood_cell | 1.24032898 |
| 70 | MP0003634_abnormal_glial_cell | 1.19898402 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.19479422 |
| 72 | MP0004147_increased_porphyrin_level | 1.19256804 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.18468375 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.17419219 |
| 75 | MP0002254_reproductive_system_inflammat | 1.17260062 |
| 76 | MP0004510_myositis | 1.16477888 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.15475387 |
| 78 | MP0003329_amyloid_beta_deposits | 1.15362144 |
| 79 | MP0003279_aneurysm | 1.14910328 |
| 80 | MP0005000_abnormal_immune_tolerance | 1.14778269 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.11852921 |
| 82 | MP0004036_abnormal_muscle_relaxation | 1.11599408 |
| 83 | MP0003091_abnormal_cell_migration | 1.11150285 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 1.10651606 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.10536506 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 1.09154135 |
| 87 | MP0004883_abnormal_blood_vessel | 1.05224723 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 1.05032593 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 1.03173043 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 1.02031327 |
| 91 | MP0002971_abnormal_brown_adipose | 0.99086754 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.99002502 |
| 93 | MP0000749_muscle_degeneration | 0.98341126 |
| 94 | MP0004885_abnormal_endolymph | 0.97944493 |
| 95 | MP0009785_altered_susceptibility_to | 0.96557771 |
| 96 | MP0001873_stomach_inflammation | 0.95464616 |
| 97 | MP0005671_abnormal_response_to | 0.95196976 |
| 98 | MP0001905_abnormal_dopamine_level | 0.94826480 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.94534724 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.94075075 |
| 101 | MP0002928_abnormal_bile_duct | 0.93497400 |
| 102 | MP0000604_amyloidosis | 0.92343660 |
| 103 | MP0000462_abnormal_digestive_system | 0.92166020 |
| 104 | MP0005390_skeleton_phenotype | 0.91900386 |
| 105 | MP0002168_other_aberrant_phenotype | 0.90306851 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.89148004 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.89106797 |
| 108 | MP0005164_abnormal_response_to | 0.88906212 |
| 109 | MP0004270_analgesia | 0.88726438 |
| 110 | MP0003252_abnormal_bile_duct | 0.88501984 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.87823308 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.87679051 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.86589212 |
| 114 | MP0001835_abnormal_antigen_presentation | 0.85115383 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.84991768 |
| 116 | MP0005166_decreased_susceptibility_to | 0.84598024 |
| 117 | MP0003828_pulmonary_edema | 0.83800365 |
| 118 | MP0001915_intracranial_hemorrhage | 0.83337392 |
| 119 | MP0005025_abnormal_response_to | 0.83118876 |
| 120 | MP0002102_abnormal_ear_morphology | 0.82820792 |
| 121 | MP0000569_abnormal_digit_pigmentation | 0.81898294 |
| 122 | MP0001853_heart_inflammation | 0.80899631 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.80759901 |
| 124 | MP0009764_decreased_sensitivity_to | 0.80239209 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.79732849 |
| 126 | MP0004233_abnormal_muscle_weight | 0.77575931 |
| 127 | MP0002723_abnormal_immune_serum | 0.77321650 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.75607507 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.75607507 |
| 130 | MP0000639_abnormal_adrenal_gland | 0.75185258 |
| 131 | MP0003633_abnormal_nervous_system | 0.74403498 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.73709394 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.71665393 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.71611954 |
| 135 | MP0000003_abnormal_adipose_tissue | 0.70863730 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.70540971 |
| 137 | MP0003795_abnormal_bone_structure | 0.70185587 |
| 138 | MP0002452_abnormal_antigen_presenting | 0.70000948 |
| 139 | MP0005535_abnormal_body_temperature | 0.69992419 |
| 140 | MP0009763_increased_sensitivity_to | 0.69951548 |
| 141 | MP0005174_abnormal_tail_pigmentation | 0.69619330 |
| 142 | MP0005332_abnormal_amino_acid | 0.69137580 |
| 143 | MP0002420_abnormal_adaptive_immunity | 0.67961422 |
| 144 | MP0001270_distended_abdomen | 0.67640415 |
| 145 | MP0003011_delayed_dark_adaptation | 0.67622536 |
| 146 | MP0000733_abnormal_muscle_development | 0.67608232 |
| 147 | MP0001501_abnormal_sleep_pattern | 0.67437392 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67399056 |
| 149 | MP0001819_abnormal_immune_cell | 0.67131164 |
| 150 | MP0001944_abnormal_pancreas_morphology | 0.65760711 |
| 151 | MP0004142_abnormal_muscle_tone | 0.64568729 |
| 152 | MP0008995_early_reproductive_senescence | 0.62730776 |
| 153 | MP0001919_abnormal_reproductive_system | 0.62505172 |
| 154 | MP0000015_abnormal_ear_pigmentation | 0.61148227 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.60790479 |
| 156 | MP0002396_abnormal_hematopoietic_system | 0.60456277 |
| 157 | MP0003283_abnormal_digestive_organ | 0.60314243 |
| 158 | MP0001663_abnormal_digestive_system | 0.59980860 |
| 159 | MP0000249_abnormal_blood_vessel | 0.59818390 |
| 160 | MP0000372_irregular_coat_pigmentation | 0.58396015 |
| 161 | MP0002132_abnormal_respiratory_system | 0.57038940 |
| 162 | MP0001765_abnormal_ion_homeostasis | 0.56604752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.33646062 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.93796769 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56158092 |
| 4 | Optic neuritis (HP:0100653) | 4.44759703 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.44759703 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.44438777 |
| 7 | T lymphocytopenia (HP:0005403) | 4.41986944 |
| 8 | Myositis (HP:0100614) | 4.24613677 |
| 9 | Orchitis (HP:0100796) | 4.06331708 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.03695597 |
| 11 | Eczematoid dermatitis (HP:0000976) | 4.02067924 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.83890344 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.82440480 |
| 14 | Thyroiditis (HP:0100646) | 3.57999289 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.44898493 |
| 16 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.39705689 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.39705689 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 3.36047291 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.35835982 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.34994668 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.33802115 |
| 22 | Male infertility (HP:0003251) | 3.31795665 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.28962239 |
| 24 | Abnormality of T cells (HP:0002843) | 3.24151528 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.23609017 |
| 26 | Hematochezia (HP:0002573) | 3.23158757 |
| 27 | Leukocytosis (HP:0001974) | 3.17190614 |
| 28 | Encephalitis (HP:0002383) | 3.15216181 |
| 29 | Increased IgM level (HP:0003496) | 3.11489895 |
| 30 | Thickened helices (HP:0000391) | 3.10140500 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.09011646 |
| 32 | Metaphyseal dysplasia (HP:0100255) | 3.07911678 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07793690 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07793690 |
| 35 | Meningitis (HP:0001287) | 3.02267609 |
| 36 | Vasculitis (HP:0002633) | 2.97491225 |
| 37 | Abnormality of eosinophils (HP:0001879) | 2.95003879 |
| 38 | IgG deficiency (HP:0004315) | 2.94914171 |
| 39 | Recurrent skin infections (HP:0001581) | 2.89528270 |
| 40 | Clumsiness (HP:0002312) | 2.87577587 |
| 41 | Deep venous thrombosis (HP:0002625) | 2.85986162 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.84506977 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.84214162 |
| 44 | Eosinophilia (HP:0001880) | 2.83624088 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.76981168 |
| 46 | Hemoptysis (HP:0002105) | 2.76059186 |
| 47 | Stridor (HP:0010307) | 2.75367473 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75013734 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.71059329 |
| 50 | Intrahepatic cholestasis (HP:0001406) | 2.65586169 |
| 51 | Pancreatic cysts (HP:0001737) | 2.60106428 |
| 52 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.59477804 |
| 53 | Vascular tortuosity (HP:0004948) | 2.58156396 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.57784818 |
| 55 | Obstructive lung disease (HP:0006536) | 2.57784818 |
| 56 | Loss of speech (HP:0002371) | 2.57490898 |
| 57 | Arterial tortuosity (HP:0005116) | 2.55219668 |
| 58 | Increased cerebral lipofuscin (HP:0011813) | 2.53671342 |
| 59 | Joint swelling (HP:0001386) | 2.52936060 |
| 60 | Epiphyseal dysplasia (HP:0002656) | 2.52769902 |
| 61 | Pustule (HP:0200039) | 2.52377571 |
| 62 | Cerebral hemorrhage (HP:0001342) | 2.50891390 |
| 63 | Increased CSF protein (HP:0002922) | 2.48387703 |
| 64 | Premature skin wrinkling (HP:0100678) | 2.47531510 |
| 65 | Abnormality of T cell physiology (HP:0011840) | 2.47384392 |
| 66 | Exercise-induced myalgia (HP:0003738) | 2.46963091 |
| 67 | Malnutrition (HP:0004395) | 2.46902540 |
| 68 | Axonal loss (HP:0003447) | 2.46496886 |
| 69 | Amyloidosis (HP:0011034) | 2.45640871 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.43464685 |
| 71 | Granulocytopenia (HP:0001913) | 2.42556939 |
| 72 | Episodic fever (HP:0001954) | 2.40793226 |
| 73 | Spondylolisthesis (HP:0003302) | 2.38641555 |
| 74 | Chest pain (HP:0100749) | 2.38393092 |
| 75 | Pulmonary embolism (HP:0002204) | 2.36910979 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.32313879 |
| 77 | Arterial thrombosis (HP:0004420) | 2.27484789 |
| 78 | Cholecystitis (HP:0001082) | 2.26862906 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.26862906 |
| 80 | Alveolar cell carcinoma (HP:0006519) | 2.24591524 |
| 81 | Gangrene (HP:0100758) | 2.24346230 |
| 82 | Recurrent viral infections (HP:0004429) | 2.24237018 |
| 83 | Large for gestational age (HP:0001520) | 2.23941852 |
| 84 | Hypoplastic ischia (HP:0003175) | 2.22264094 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.19366758 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.18364975 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.16737328 |
| 88 | Abnormality of midbrain morphology (HP:0002418) | 2.16737328 |
| 89 | Supranuclear gaze palsy (HP:0000605) | 2.16371810 |
| 90 | Stomach cancer (HP:0012126) | 2.16339097 |
| 91 | Abnormal tarsal ossification (HP:0008369) | 2.16033449 |
| 92 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.15928106 |
| 93 | Acute hepatic failure (HP:0006554) | 2.15763532 |
| 94 | Gowers sign (HP:0003391) | 2.15631280 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.13521657 |
| 96 | Abnormality of macrophages (HP:0004311) | 2.12921334 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 2.11759902 |
| 98 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.11759902 |
| 99 | Aplasia of the phalanges of the hand (HP:0009802) | 2.11759902 |
| 100 | Disproportionate short-trunk short stature (HP:0003521) | 2.09271582 |
| 101 | Nonprogressive disorder (HP:0003680) | 2.06352329 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.06223551 |
| 103 | Tetraparesis (HP:0002273) | 2.06141498 |
| 104 | Abnormality of the ischium (HP:0003174) | 2.05615257 |
| 105 | Keratitis (HP:0000491) | 2.05500670 |
| 106 | Abnormality of the corticospinal tract (HP:0002492) | 2.04930720 |
| 107 | Hyperlipoproteinemia (HP:0010980) | 2.03806832 |
| 108 | Anteriorly placed anus (HP:0001545) | 2.03776561 |
| 109 | Papilledema (HP:0001085) | 2.03646837 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 2.03046483 |
| 111 | Hyperkalemia (HP:0002153) | 2.02190977 |
| 112 | Onion bulb formation (HP:0003383) | 2.01866776 |
| 113 | Gingivitis (HP:0000230) | 2.01209925 |
| 114 | Hypochromic anemia (HP:0001931) | 2.00383055 |
| 115 | Chronic diarrhea (HP:0002028) | 1.99149538 |
| 116 | Hypoproteinemia (HP:0003075) | 1.98277694 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.98237984 |
| 118 | Retinal dysplasia (HP:0007973) | 1.97992145 |
| 119 | Barrel-shaped chest (HP:0001552) | 1.97949029 |
| 120 | Flat acetabular roof (HP:0003180) | 1.97722168 |
| 121 | Disinhibition (HP:0000734) | 1.97179458 |
| 122 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.96702576 |
| 123 | Abnormal auditory evoked potentials (HP:0006958) | 1.96366934 |
| 124 | Muscle fiber inclusion bodies (HP:0100299) | 1.96188328 |
| 125 | Anorexia (HP:0002039) | 1.95882989 |
| 126 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.95694433 |
| 127 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94219965 |
| 128 | Spastic paraparesis (HP:0002313) | 1.93083528 |
| 129 | Hyporeflexia of lower limbs (HP:0002600) | 1.92335079 |
| 130 | Nemaline bodies (HP:0003798) | 1.91967962 |
| 131 | Ovoid vertebral bodies (HP:0003300) | 1.91228821 |
| 132 | Pancreatic fibrosis (HP:0100732) | 1.91220317 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91003663 |
| 134 | Steatorrhea (HP:0002570) | 1.90336938 |
| 135 | Recurrent bronchitis (HP:0002837) | 1.88414579 |
| 136 | Attenuation of retinal blood vessels (HP:0007843) | 1.87928430 |
| 137 | White forelock (HP:0002211) | 1.87428126 |
| 138 | Hypoplasia of the odontoid process (HP:0003311) | 1.87000536 |
| 139 | Paraparesis (HP:0002385) | 1.86960902 |
| 140 | Widely spaced teeth (HP:0000687) | 1.86767291 |
| 141 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86609435 |
| 142 | Abnormality of B cell number (HP:0010975) | 1.85890730 |
| 143 | Increased IgE level (HP:0003212) | 1.85751725 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.85580110 |
| 145 | Abnormal drinking behavior (HP:0030082) | 1.85204205 |
| 146 | Polydipsia (HP:0001959) | 1.85204205 |
| 147 | Patchy hypopigmentation of hair (HP:0011365) | 1.83706825 |
| 148 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83043040 |
| 149 | Abnormality of the pleura (HP:0002103) | 1.82437787 |
| 150 | Epistaxis (HP:0000421) | 1.81709325 |
| 151 | Lymphopenia (HP:0001888) | 1.81478972 |
| 152 | Generalized myoclonic seizures (HP:0002123) | 1.81164698 |
| 153 | Neoplasm of the adrenal cortex (HP:0100641) | 1.81132977 |
| 154 | True hermaphroditism (HP:0010459) | 1.80533311 |
| 155 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80426764 |
| 156 | Protuberant abdomen (HP:0001538) | 1.80348713 |
| 157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80232273 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.80232273 |
| 159 | Polyneuropathy (HP:0001271) | 1.80100685 |
| 160 | Fat malabsorption (HP:0002630) | 1.79676326 |
| 161 | Abolished electroretinogram (ERG) (HP:0000550) | 1.79498605 |
| 162 | Urticaria (HP:0001025) | 1.78679747 |
| 163 | Premature rupture of membranes (HP:0001788) | 1.77797819 |
| 164 | Fair hair (HP:0002286) | 1.76302976 |
| 165 | Myocardial infarction (HP:0001658) | 1.75728444 |
| 166 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75436831 |
| 167 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75436831 |
| 168 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75436831 |
| 169 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75254601 |
| 170 | Hypoplasia of the iris (HP:0007676) | 1.74232336 |
| 171 | Hemorrhage of the eye (HP:0011885) | 1.73365494 |
| 172 | Verrucae (HP:0200043) | 1.73282416 |
| 173 | Papilloma (HP:0012740) | 1.73282416 |
| 174 | Chronic bronchitis (HP:0004469) | 1.71315978 |
| 175 | Potter facies (HP:0002009) | 1.70178722 |
| 176 | Facial shape deformation (HP:0011334) | 1.70178722 |
| 177 | Vacuolated lymphocytes (HP:0001922) | 1.69765972 |
| 178 | Intention tremor (HP:0002080) | 1.69032725 |
| 179 | Xanthomatosis (HP:0000991) | 1.68345608 |
| 180 | Sensory axonal neuropathy (HP:0003390) | 1.67772422 |
| 181 | Gingival bleeding (HP:0000225) | 1.67771276 |
| 182 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67389977 |
| 183 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67389977 |
| 184 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67389977 |
| 185 | Progressive visual loss (HP:0000529) | 1.65921775 |
| 186 | Abnormal gallbladder morphology (HP:0012437) | 1.65871601 |
| 187 | Dysmetria (HP:0001310) | 1.65780128 |
| 188 | Tetany (HP:0001281) | 1.65328237 |
| 189 | Exercise-induced muscle cramps (HP:0003710) | 1.64243080 |
| 190 | Spontaneous hematomas (HP:0007420) | 1.64014839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.99466925 |
| 2 | FRK | 3.94308306 |
| 3 | TAOK3 | 3.53362994 |
| 4 | STK39 | 3.30149532 |
| 5 | EPHB1 | 3.20286951 |
| 6 | MAP4K1 | 3.18396295 |
| 7 | BMPR2 | 2.53709091 |
| 8 | MAP3K6 | 2.33163305 |
| 9 | PRPF4B | 2.24440198 |
| 10 | OXSR1 | 2.18299602 |
| 11 | MOS | 2.08081881 |
| 12 | ERN1 | 2.00252573 |
| 13 | DMPK | 1.98077892 |
| 14 | FES | 1.92490864 |
| 15 | MELK | 1.82793390 |
| 16 | BMPR1B | 1.77843035 |
| 17 | FGFR2 | 1.77610461 |
| 18 | MAP3K13 | 1.74233989 |
| 19 | WNK4 | 1.73993823 |
| 20 | LATS1 | 1.71573976 |
| 21 | PRKD3 | 1.71536041 |
| 22 | SYK | 1.69931176 |
| 23 | BLK | 1.63127182 |
| 24 | TEC | 1.61451537 |
| 25 | SIK3 | 1.55353155 |
| 26 | TYRO3 | 1.52379326 |
| 27 | LCK | 1.51855223 |
| 28 | IKBKB | 1.49778487 |
| 29 | INSRR | 1.48470988 |
| 30 | ZAP70 | 1.47383582 |
| 31 | CAMKK2 | 1.44291625 |
| 32 | MAP4K2 | 1.44043306 |
| 33 | BTK | 1.42140775 |
| 34 | KSR2 | 1.39172434 |
| 35 | GRK6 | 1.35049071 |
| 36 | STK10 | 1.34047835 |
| 37 | TRIM28 | 1.31400564 |
| 38 | HCK | 1.29013036 |
| 39 | ICK | 1.28948320 |
| 40 | PASK | 1.23288562 |
| 41 | NEK6 | 1.23085744 |
| 42 | AKT3 | 1.22097068 |
| 43 | MAPK7 | 1.22049830 |
| 44 | LYN | 1.20978468 |
| 45 | TNIK | 1.20851840 |
| 46 | PINK1 | 1.19941614 |
| 47 | EPHA3 | 1.19626040 |
| 48 | FGFR4 | 1.19313414 |
| 49 | SGK223 | 1.18123676 |
| 50 | SGK494 | 1.18123676 |
| 51 | PIK3CG | 1.15293070 |
| 52 | TNK2 | 1.15025473 |
| 53 | CDK19 | 1.13915948 |
| 54 | PRKCH | 1.13133828 |
| 55 | MET | 1.12535953 |
| 56 | PKN1 | 1.12189119 |
| 57 | ERBB4 | 1.08190535 |
| 58 | WNK1 | 1.07471577 |
| 59 | ADRBK2 | 1.07450230 |
| 60 | MAP3K14 | 1.05417075 |
| 61 | KIT | 1.03859480 |
| 62 | STK3 | 1.03381391 |
| 63 | MAPKAPK5 | 1.03301333 |
| 64 | GRK7 | 1.01684397 |
| 65 | CDK9 | 1.00677676 |
| 66 | JAK1 | 0.99912215 |
| 67 | PRKCQ | 0.95663865 |
| 68 | PAK6 | 0.94721529 |
| 69 | PDPK1 | 0.94621171 |
| 70 | MAP3K4 | 0.93915916 |
| 71 | CSK | 0.92555936 |
| 72 | HIPK2 | 0.92142524 |
| 73 | TRIB3 | 0.91650926 |
| 74 | YES1 | 0.91268642 |
| 75 | BCR | 0.88571189 |
| 76 | TRPM7 | 0.87065225 |
| 77 | ITK | 0.85253112 |
| 78 | NLK | 0.83336525 |
| 79 | IKBKE | 0.83304064 |
| 80 | SGK3 | 0.80750571 |
| 81 | BCKDK | 0.79873705 |
| 82 | CSNK1G1 | 0.78067525 |
| 83 | TGFBR1 | 0.77256759 |
| 84 | IRAK4 | 0.76593762 |
| 85 | DYRK2 | 0.75530340 |
| 86 | TYK2 | 0.75436291 |
| 87 | TGFBR2 | 0.74594211 |
| 88 | TAOK1 | 0.74578282 |
| 89 | PDK1 | 0.74216851 |
| 90 | GRK1 | 0.72412207 |
| 91 | BRAF | 0.72110256 |
| 92 | PIK3CA | 0.70874568 |
| 93 | CHUK | 0.70689746 |
| 94 | EPHA4 | 0.69916462 |
| 95 | JAK2 | 0.69297977 |
| 96 | RAF1 | 0.68880896 |
| 97 | LATS2 | 0.67717156 |
| 98 | PDGFRB | 0.67343426 |
| 99 | CSNK1G2 | 0.67318065 |
| 100 | CAMKK1 | 0.67266843 |
| 101 | PAK3 | 0.67188835 |
| 102 | SGK2 | 0.66807983 |
| 103 | ERBB3 | 0.66620462 |
| 104 | PTK2B | 0.66528668 |
| 105 | PRKD2 | 0.66298487 |
| 106 | IRAK2 | 0.66097110 |
| 107 | ACVR1B | 0.65795116 |
| 108 | RET | 0.65506542 |
| 109 | RIPK4 | 0.65264028 |
| 110 | JAK3 | 0.64859295 |
| 111 | PBK | 0.63134986 |
| 112 | MAPK13 | 0.63103822 |
| 113 | CSNK1A1L | 0.63002856 |
| 114 | MST4 | 0.62455617 |
| 115 | MAP3K1 | 0.61685047 |
| 116 | GSK3A | 0.60570945 |
| 117 | FGR | 0.59855369 |
| 118 | ARAF | 0.59327190 |
| 119 | MARK3 | 0.57473785 |
| 120 | PRKAA2 | 0.57050753 |
| 121 | ABL2 | 0.56978487 |
| 122 | PLK2 | 0.56758907 |
| 123 | PDK4 | 0.54463780 |
| 124 | PDK3 | 0.54463780 |
| 125 | MAPK15 | 0.54338501 |
| 126 | STK24 | 0.54017525 |
| 127 | TBK1 | 0.53667183 |
| 128 | IRAK1 | 0.52154701 |
| 129 | TIE1 | 0.52102303 |
| 130 | MUSK | 0.51985712 |
| 131 | SIK2 | 0.51692487 |
| 132 | CSF1R | 0.51538465 |
| 133 | MAP2K7 | 0.51180876 |
| 134 | STK11 | 0.51036135 |
| 135 | BRD4 | 0.50768931 |
| 136 | STK38 | 0.49657014 |
| 137 | PRKAA1 | 0.49298507 |
| 138 | CSNK1G3 | 0.48737784 |
| 139 | NUAK1 | 0.48229570 |
| 140 | ABL1 | 0.47774376 |
| 141 | PDK2 | 0.47341448 |
| 142 | PRKD1 | 0.47160827 |
| 143 | MAP3K3 | 0.47110624 |
| 144 | UHMK1 | 0.45244473 |
| 145 | ADRBK1 | 0.44844627 |
| 146 | MATK | 0.43844807 |
| 147 | ROCK2 | 0.43363404 |
| 148 | FLT3 | 0.43152649 |
| 149 | FGFR3 | 0.42990620 |
| 150 | MAP3K5 | 0.42755973 |
| 151 | MAP3K12 | 0.42349641 |
| 152 | TLK1 | 0.41250619 |
| 153 | DYRK1B | 0.40938024 |
| 154 | LRRK2 | 0.40191760 |
| 155 | MAP3K2 | 0.39603743 |
| 156 | FYN | 0.37789772 |
| 157 | PRKG1 | 0.37236006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.90175007 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.84248941 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.81581157 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.74544370 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.70159379 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.29416566 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.25030100 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19211246 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99280754 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.91198690 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.82891740 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80561201 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79584129 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73807287 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71610727 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.69451901 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68878646 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51688779 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.50916819 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40873280 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.39916851 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37655102 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.33915448 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.32993910 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27697447 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.27211247 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.24625439 |
| 28 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.20894218 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.19986580 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19121643 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.18188435 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18135320 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15308886 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15138827 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13627251 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13501443 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13095954 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11095371 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09439465 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09279723 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08524752 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06874572 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03490061 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02502163 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01537607 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00779891 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99220320 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97980802 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96310161 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95391137 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94740174 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92751150 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91758267 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90467035 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88752045 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.86198630 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85868917 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.83618737 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82594619 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80701127 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80265756 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79558792 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78179532 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77796973 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.77164309 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76770505 |
| 67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75518458 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.74498767 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74286076 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72867819 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.72424656 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71486763 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70967877 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70203839 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.69837261 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69368821 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69176322 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67489136 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67178809 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65491163 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.65484040 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65375406 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64616103 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64034287 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62994326 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62744697 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61972405 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60953667 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60672076 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.60489601 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60261410 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.60224728 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.59632724 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59341065 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59071536 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58171442 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57389446 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57274985 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57119575 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55481028 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.54963286 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54382379 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53609059 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53404524 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53073014 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53027270 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52959179 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.52572056 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52117622 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51819079 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51566473 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51423719 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50934918 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50735519 |
| 115 | Phototransduction_Homo sapiens_hsa04744 | 0.50199253 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49257019 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48905653 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48443387 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.48272404 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47802467 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47675829 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47604477 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47399454 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46840734 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46468637 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.46060999 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.45716623 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.45551469 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45287069 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44040902 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43976734 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43656660 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43558224 |
| 134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43389808 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43325403 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.43273253 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42917687 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.41629751 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41001216 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40889114 |
| 141 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38177598 |
| 142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37860723 |
| 143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37011669 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33752283 |
| 145 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33442828 |
| 146 | Renin secretion_Homo sapiens_hsa04924 | 0.32006119 |

